|
Market Closed -
Other stock markets
|
After hours 21:48:07 | |||
| 225.18 USD | +0.98% |
|
224.85 | -0.15% |
| 09:21pm | Fresenius Medical Care Announces Global Chief Medical Officer and Board Changes | CI |
| 01:58pm | This Is Decision Day |  |
| Capitalization | 394B 338B 316B 296B 545B 35,424B 594B 3,669B 1,430B 16,791B 1,479B 1,448B 61,624B | P/E ratio 2025 * |
52x | P/E ratio 2026 * | 22.8x |
|---|---|---|---|---|---|
| Enterprise value | 450B 386B 361B 338B 623B 40,459B 678B 4,191B 1,633B 19,178B 1,689B 1,653B 70,383B | EV / Sales 2025 * |
7.39x | EV / Sales 2026 * | 6.61x |
| Free-Float |
96.39% | Yield 2025 * |
2.93% | Yield 2026 * | 3.05% |
Last Transcript: AbbVie Inc.
| 1 day | +0.83% | ||
| 1 week | -2.20% | ||
| Current month | -1.11% | ||
| 1 month | +2.96% | ||
| 3 months | +6.40% | ||
| 6 months | +18.83% | ||
| Current year | +26.72% |
| 1 week | 220.23 |  | 230.94 |
| 1 month | 219 | | 239.29 |
| Current year | 164.39 | | 244.81 |
| 1 year | 164.39 | | 244.81 |
| 3 years | 130.96 | | 244.81 |
| 5 years | 101.55 | | 244.81 |
| 10 years | 50.71 | | 244.81 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Michael
CEO | Chief Executive Officer | 54 | 30/06/2024 |
Scott Reents
DFI | Director of Finance/CFO | 58 | 22/06/2022 |
Roopal Thakkar
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/2002 |
| Director | Title | Age | Since |
|---|---|---|---|
Roxanne Austin
BRD | Director/Board Member | 64 | 31/12/2012 |
William Burnside
BRD | Director/Board Member | 73 | 31/12/2012 |
Edward Rapp
BRD | Director/Board Member | 67 | 31/12/2012 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 7.12% | 6 M€ | 0.00% | - |
| 6.85% | 26 M€ | +11.19% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.98% | -2.20% | +28.18% | +36.21% | 394B | |
| +1.16% | -3.86% | +24.27% | +170.56% | 879B | |
| +3.29% | +0.59% | +38.40% | +16.14% | 482B | |
| +2.12% | +2.78% | +25.19% | +5.71% | 335B | |
| -0.57% | -2.07% | +26.28% | +19.02% | 281B | |
| -1.31% | -0.73% | +17.95% | +23.33% | 254B | |
| +0.75% | -4.55% | -3.35% | -10.42% | 240B | |
| +3.31% | +0.67% | -60.49% | -32.93% | 207B | |
| +0.49% | -8.70% | +14.37% | +13.95% | 169B | |
| +1.66% | -2.93% | +31.41% | +37.05% | 148B | |
| Average | +1.04% | -2.72% | +14.22% | +27.86% | 338.97B | |
| Weighted average by Cap. | +1.21% | -3.02% | +19.20% | +54.21% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 60.94B 52.32B 48.93B 45.71B 84.34B 5,477B 91.77B 567B 221B 2,596B 229B 224B 9,529B | 66.64B 57.22B 53.51B 49.99B 92.23B 5,990B 100B 620B 242B 2,839B 250B 245B 10,420B |
| Net income | 9.1B 7.81B 7.31B 6.82B 12.59B 818B 13.7B 84.71B 33.01B 388B 34.14B 33.42B 1,423B | 17.43B 14.96B 13.99B 13.07B 24.12B 1,567B 26.25B 162B 63.23B 743B 65.4B 64.02B 2,725B |
| Net Debt | 56.02B 48.1B 44.98B 42.02B 77.53B 5,035B 84.36B 522B 203B 2,387B 210B 206B 8,759B | 46.57B 39.99B 37.4B 34.94B 64.46B 4,186B 70.14B 434B 169B 1,984B 175B 171B 7,282B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/12/25 | 225.18 $ | +0.98% | 8,485,797 |
| 09/12/25 | 222.99 $ | -0.06% | 4,268,052 |
| 08/12/25 | 223.12 $ | -1.31% | 4,006,095 |
| 05/12/25 | 226.08 $ | -1.15% | 3,985,199 |
| 04/12/25 | 228.71 $ | -0.66% | 3,733,100 |
Delayed Quote Nyse, December 10, 2025 at 09:00 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ABBV Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition